FERMENTAPharmaceuticals
Fermenta Biotech Ltd — Cash Flow Statement
₹319.05
-4.70%
Fermenta Biotech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 18.77 Cr | 86.14 Cr | 75.62 Cr | 6.31 Cr | — |
| Repayment Of Debt | -35.82 Cr | -72.29 Cr | -53.96 Cr | -21.23 Cr | — |
| Issuance Of Debt | 0.00 | 3.05 Cr | 36.31 Cr | 24.90 Cr | — |
| Issuance Of Capital Stock | 2.47 Cr | 0.00 | — | — | — |
| Capital Expenditure | -22.13 Cr | -19.21 Cr | -40.49 Cr | -37.13 Cr | — |
| End Cash Position | 6.63 Cr | 16.75 Cr | 17.75 Cr | -1.88 Cr | — |
| Other Cash Adjustment Outside Changein Cash | -1000.00 | — | 0.05 Cr | — | 0.61 Cr |
| Beginning Cash Position | 16.75 Cr | 17.75 Cr | -1.61 Cr | 2.29 Cr | — |
| Changes In Cash | -10.12 Cr | -1.00 Cr | 19.32 Cr | -4.17 Cr | — |
| Financing Cash Flow | -50.87 Cr | -90.85 Cr | -41.38 Cr | -21.58 Cr | — |
| Interest Paid Cff | -12.45 Cr | -16.66 Cr | -20.54 Cr | -16.67 Cr | — |
| Cash Dividends Paid | -3.61 Cr | -3.61 Cr | -4.20 Cr | -7.21 Cr | — |
| Net Common Stock Issuance | 2.47 Cr | 0.00 | — | — | — |
| Common Stock Issuance | 2.47 Cr | 0.00 | — | — | — |
| Net Issuance Payments Of Debt | -35.82 Cr | -69.24 Cr | -15.36 Cr | 3.67 Cr | — |
| Net Short Term Debt Issuance | -2.48 Cr | -21.82 Cr | 2.29 Cr | 0.60 Cr | — |
| Short Term Debt Payments | -2.48 Cr | -21.82 Cr | — | — | — |
| Net Long Term Debt Issuance | -33.34 Cr | -47.42 Cr | -17.65 Cr | 3.07 Cr | — |
| Long Term Debt Payments | -33.34 Cr | -50.48 Cr | -53.96 Cr | -21.23 Cr | — |
| Long Term Debt Issuance | 0.00 | 3.05 Cr | 36.31 Cr | 24.30 Cr | — |
| Investing Cash Flow | -0.16 Cr | -15.50 Cr | -55.41 Cr | -26.04 Cr | — |
| Interest Received Cfi | 3.12 Cr | 2.47 Cr | 1.70 Cr | 2.36 Cr | — |
| Dividends Received Cfi | 0.91 Cr | 0.90 Cr | 0.91 Cr | 0.00 | — |
| Net Investment Purchase And Sale | -5.10 Cr | 4.03 Cr | -16.39 Cr | 3.88 Cr | — |
| Net PPE Purchase And Sale | -2.88 Cr | -19.14 Cr | -40.44 Cr | -37.04 Cr | — |
| Sale Of PPE | 19.25 Cr | 0.07 Cr | 0.05 Cr | 0.09 Cr | — |
| Purchase Of PPE | -22.13 Cr | -19.21 Cr | -40.49 Cr | -37.13 Cr | — |
| Operating Cash Flow | 40.90 Cr | 105.35 Cr | 116.11 Cr | 43.44 Cr | — |
| Taxes Refund Paid | -2.77 Cr | 1.02 Cr | 3.21 Cr | -9.31 Cr | — |
| Change In Working Capital | -82.50 Cr | 32.70 Cr | 44.95 Cr | -17.38 Cr | — |
| Change In Other Current Liabilities | -2.21 Cr | -3.92 Cr | 16.86 Cr | -2.28 Cr | — |
| Change In Other Current Assets | -24.81 Cr | 4.43 Cr | -2.29 Cr | -5.84 Cr | — |
| Change In Payable | 13.79 Cr | 24.32 Cr | -15.27 Cr | 3.13 Cr | — |
| Change In Inventory | -36.27 Cr | 42.76 Cr | 9.93 Cr | 2.79 Cr | — |
| Change In Receivables | -34.16 Cr | -33.95 Cr | 35.31 Cr | -17.02 Cr | — |
| Other Non Cash Items | 8.29 Cr | 15.23 Cr | 43.71 Cr | 14.84 Cr | — |
| Stock Based Compensation | 0.00 | 0.19 Cr | -1.02 Cr | 2.70 Cr | — |
| Provisionand Write Offof Assets | 1.17 Cr | 0.86 Cr | 0.52 Cr | 1.41 Cr | — |
| Depreciation And Amortization | 24.22 Cr | 24.72 Cr | 28.25 Cr | 25.56 Cr | — |
| Amortization Cash Flow | 4.21 Cr | 4.21 Cr | 6.84 Cr | 4.35 Cr | — |
| Depreciation | 20.01 Cr | 20.51 Cr | 21.41 Cr | 21.21 Cr | — |
| Gain Loss On Investment Securities | 45.72 Cr | 100.55 Cr | 91.68 Cr | -0.87 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 3.18 Cr | 3.50 Cr | -1.24 Cr | -0.52 Cr | — |
| Gain Loss On Sale Of PPE | -39.62 Cr | -63.55 Cr | -47.41 Cr | 0.03 Cr | — |
| Net Income From Continuing Operations | 83.21 Cr | -9.87 Cr | -51.31 Cr | 26.94 Cr | — |
| Net Other Financing Charges | — | -50000.00 | — | — | — |
| Short Term Debt Issuance | — | — | 2.29 Cr | 0.60 Cr | 3.58 Cr |
| Net Business Purchase And Sale | — | — | — | 0.00 | -9.44 Cr |
| Purchase Of Business | — | — | — | 0.00 | -9.44 Cr |
| Net Other Investing Changes | — | — | — | — | -2.20 Cr |
| Sale Of Investment | — | — | — | — | 20.55 Cr |
| Purchase Of Investment | — | — | — | — | -2.20 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Fermenta Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.